Health Trials

Lung Metastatic Nasopharyngeal Carcinoma

1

Review clinical trials related to Lung Metastatic Nasopharyngeal Carcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma

This study is a retrospective real-world study. In this study, we plan to collect the clinical data of lung metastatic nasopharyngeal carcinoma patients who received PD-1 inhibitors and chemotherapy combined with or without radiotherapy.

Participants needed: 600
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Sichuan Cancer Hospital and Research InstituteUpdated: Jul 14, 2025Locations: 1
Eligibility criteria

age of at least 18 years; [+5]

previous treatment with an immune checkpoint inhibitor; [+8]

Read more